328 related articles for article (PubMed ID: 19736973)
1. Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems.
Rosenholm JM; Peuhu E; Eriksson JE; Sahlgren C; Lindén M
Nano Lett; 2009 Sep; 9(9):3308-11. PubMed ID: 19736973
[TBL] [Abstract][Full Text] [Related]
2. On the intracellular release mechanism of hydrophobic cargo and its relation to the biodegradation behavior of mesoporous silica nanocarriers.
von Haartman E; Lindberg D; Prabhakar N; Rosenholm JM
Eur J Pharm Sci; 2016 Dec; 95():17-27. PubMed ID: 27267567
[TBL] [Abstract][Full Text] [Related]
3. Intracellular degradation of multilabeled poly(ethylene imine)-mesoporous silica-silica nanoparticles: implications for drug release.
Bergman L; Kankaanpää P; Tiitta S; Duchanoy A; Li L; Heino J; Lindén M
Mol Pharm; 2013 May; 10(5):1795-803. PubMed ID: 23510188
[TBL] [Abstract][Full Text] [Related]
4. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
[TBL] [Abstract][Full Text] [Related]
5. Polyvalent nucleic acid/mesoporous silica nanoparticle conjugates: dual stimuli-responsive vehicles for intracellular drug delivery.
Chen C; Geng J; Pu F; Yang X; Ren J; Qu X
Angew Chem Int Ed Engl; 2011 Jan; 50(4):882-6. PubMed ID: 21246683
[No Abstract] [Full Text] [Related]
6. A free-blockage controlled release system based on the hydrophobic/hydrophilic conversion of mesoporous silica nanopores.
Wang W; Chen L; Xu LP; Du H; Wen Y; Song Y; Zhang X
Chemistry; 2015 Feb; 21(6):2680-5. PubMed ID: 25504676
[TBL] [Abstract][Full Text] [Related]
7. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
8. Breakable mesoporous silica nanoparticles for targeted drug delivery.
Maggini L; Cabrera I; Ruiz-Carretero A; Prasetyanto EA; Robinet E; De Cola L
Nanoscale; 2016 Apr; 8(13):7240-7. PubMed ID: 26974603
[TBL] [Abstract][Full Text] [Related]
9. Tobacco Mosaic Virus-Functionalized Mesoporous Silica Nanoparticles, a Wool-Ball-like Nanostructure for Drug Delivery.
Marín-Caba L; Chariou PL; Pesquera C; Correa-Duarte MA; Steinmetz NF
Langmuir; 2019 Jan; 35(1):203-211. PubMed ID: 30576145
[TBL] [Abstract][Full Text] [Related]
10. Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides.
Braun K; Pochert A; Lindén M; Davoudi M; Schmidtchen A; Nordström R; Malmsten M
J Colloid Interface Sci; 2016 Aug; 475():161-170. PubMed ID: 27174622
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
Lu J; Liong M; Zink JI; Tamanoi F
Small; 2007 Aug; 3(8):1341-6. PubMed ID: 17566138
[No Abstract] [Full Text] [Related]
13. Large-Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum-Acridine Anticancer Agent.
Zheng Y; Fahrenholtz CD; Hackett CL; Ding S; Day CS; Dhall R; Marrs GS; Gross MD; Singh R; Bierbach U
Chemistry; 2017 Mar; 23(14):3386-3397. PubMed ID: 28122141
[TBL] [Abstract][Full Text] [Related]
14. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.
Rosenholm JM; Mamaeva V; Sahlgren C; Lindén M
Nanomedicine (Lond); 2012 Jan; 7(1):111-20. PubMed ID: 22191780
[TBL] [Abstract][Full Text] [Related]
16. Stimuli-responsive flexible Lewis pair-modified nanoparticles for fluorescence imaging.
Arsenault NE; Downey KT; Wolf MO
Chem Commun (Camb); 2020 Jun; 56(44):5981-5984. PubMed ID: 32347856
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous Silica Nanoparticles in Cancer Therapy: Relevance of the Targeting Function.
Pasqua L; Leggio A; Sisci D; Andò S; Morelli C
Mini Rev Med Chem; 2016; 16(9):743-53. PubMed ID: 26996622
[TBL] [Abstract][Full Text] [Related]
18. Intracellular delivery of antisense peptide nucleic acid by fluorescent mesoporous silica nanoparticles.
Ma X; Devi G; Qu Q; Toh DF; Chen G; Zhao Y
Bioconjug Chem; 2014 Aug; 25(8):1412-20. PubMed ID: 25055196
[TBL] [Abstract][Full Text] [Related]
19. Anisotropic growth-induced synthesis of dual-compartment Janus mesoporous silica nanoparticles for bimodal triggered drugs delivery.
Li X; Zhou L; Wei Y; El-Toni AM; Zhang F; Zhao D
J Am Chem Soc; 2014 Oct; 136(42):15086-92. PubMed ID: 25251874
[TBL] [Abstract][Full Text] [Related]
20. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles.
Tsai CH; Vivero-Escoto JL; Slowing II; Fang IJ; Trewyn BG; Lin VS
Biomaterials; 2011 Sep; 32(26):6234-44. PubMed ID: 21684000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]